Shanghai Xiao Fang Pharmaceutical Co.,Ltd. (SHA:603207)
China · Delayed Price · Currency is CNY 29.59
-0.69 (-2.28%)
Feb 2, 2026, 4:00 PM EST
SHA:603207 Market Cap
SHA:603207 has a market cap or net worth of 4.84 billion as of February 3, 2026. Its market cap has increased by 2.11% in one year.
Market Cap
4.84B
Enterprise Value
4.11B
Revenue
504.59M
Ranking
n/a
PE Ratio
22.72
Stock Price
29.59
Market Cap Chart
Since August 26, 2024, SHA:603207's market cap has decreased from 5.33B to 4.84B, a decrease of -9.08%. That is a compound annual growth rate of -6.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 4.84B | 5.42% |
| Dec 31, 2025 | 4.60B | 2.24% |
| Dec 31, 2024 | 4.49B | -15.65% |
| Aug 26, 2024 | 5.33B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bide Pharmatech | 5.02B |
| Luoxin Pharmaceuticals Group Stock | 5.01B |
| Newland Pharmaceutical | 5.00B |
| Shanghai Jiaoda Onlly Co.,Ltd | 4.99B |
| Tibet Duo Rui Pharmaceutical | 4.94B |
| Guizhou Sanli Pharmaceutical Co.,Ltd | 4.80B |
| Tibet Weixinkang Medicine | 4.76B |
| Shandong Sinobioway Biomedicine | 4.74B |